Skip to main content
SpringerLink
Log in

Costs of developing new cancer drugs quickly recouped

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Prasad V, et al. Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval. JAMA Internal Medicine : 11 Sep 2017. Available from: URL: http://dx.doi.org/10.1001/jamainternmed.2017.3601.

  2. Goozner M. A Much-Needed Corrective on Drug Development Costs. JAMA Internal Medicine : 11 Sep 2017. Available from: URL: https://dx.doi.org/10.1001/jamainternmed.2017.4997.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Costs of developing new cancer drugs quickly recouped. PharmacoEcon Outcomes News 787, 13 (2017). https://doi.org/10.1007/s40274-017-4341-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4341-9

Search

Navigation